Gregori Casals
Publicacions destacades
-
Mesoporous silica coated CeO2 nanozymes with combined lipid-lowering and antioxidant activity induce long-term improvement of the metabolic profile in obese Zucker rats
Autors:Referència: Nanoscale 2021. -
Bespoken nanoceria: A new effective treatment in experimental hepatocellular carcinoma
Autors:Referència: Hepatology 2020. -
Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo
Autors:Referència: Nature Medicine 2018. -
Intrinsic and Extrinsic Properties Affecting Innate Immune Responses to Nanoparticles: The Case of Cerium Oxide.
Autors:Referència: Frontiers In Immunology 2017. -
Cerium oxide nanoparticles reduce steatosis, portal hypertension and display antiinflammatory properties in rats with liver fibrosis
Autors:Referència: Journal Of Hepatology 2016. -
Microwave-assisted derivatization: Application to steroid profiling by gas chromatography/mass spectrometry
Autors:Referència: Journal Of Chromatography B-Analytical Technologies In The Biomedical And Life Sciences 2014. -
Hypoxia induces B-type natriuretic peptide release in cell lines derived from human cardiomyocytes
Autors:Referència: American Journal Of Physiology-Heart And Circulatory Physiology 2009.
Projectes destacats
-
Evaluation of antioxidant and anti-inflammatory properties of cerium oxide nanoparticles as novel therapeutic strategy in hepatic steatosis.
Investigador/a principal: Gregori Casals MercadalFinançador: CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Sede o evento); Fondo de Investigación SanitariaDurada: 01/01/2016 - 01/01/2018 -
Cerium oxide nanoparticles as a new therapeutic tool for tissue regeneration in liver diseases
Investigador/a principal: Víctor Franco PuntesFinançador: CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Sede o evento); Fundació La Marató de TV3Durada: 01/01/2013 - 01/01/2015 -
Basic and translational implications of the functional and molecular alterations of the hepatic endothelium in cirrhosis
Investigador/a principal: Manuel Morales RuizFinançador: CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Sede o evento)Durada: 01/01/2011 - 01/01/2013 -
Pathophysiological role of activated liver endothelial cells in cirrhosis. Possible therapeutical implications
Investigador/a principal: Manuel Morales RuizFinançador: CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Sede o evento); Dirección General de Investigación Científica (Ministerio de Educación y Ciencia)Durada: 01/01/2008 - 01/01/2010 -
Aplicaciones de la genómica en la identificación de dianas terapéuticas específicas para el endotelio hepático en la cirrosis, función fisiopatológica de VEGF.
Investigador/a principal: Manuel Morales RuizFinançador: CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Sede o evento); Fondo de Investigación SanitariaDurada: 01/01/2005 - 01/01/2007